Andersen, S., Richardsen, E., Moi, L., Donnem, T., Nordby, Y., Ness, N., . . . Busund, L. (2016). Fibroblast miR-210 overexpression is independently associated with clinical failure in Prostate Cancer – a multicenter (in situ hybridization) study. Sci Rep.
Chicago Stili AlıntıAndersen, Sigve, Elin Richardsen, Line Moi, Tom Donnem, Yngve Nordby, Nora Ness, Marte Eilertsen Holman, Roy M. Bremnes, ve Lill-Tove Busund. "Fibroblast MiR-210 Overexpression Is Independently Associated With Clinical Failure in Prostate Cancer – a Multicenter (in Situ Hybridization) Study." Sci Rep 2016.
MLA AlıntıAndersen, Sigve, et al. "Fibroblast MiR-210 Overexpression Is Independently Associated With Clinical Failure in Prostate Cancer – a Multicenter (in Situ Hybridization) Study." Sci Rep 2016.